Stanford researchers have discovered a compound that reduces the symptoms of heart failure after a heart attack in initial animal tests.
Artificial intelligence tied to a wearable heart monitor has shown potential to help diagnose irregular heart rhythms, new research shows.
A study confirmed that patients with peripheral artery disease have a higher risk of heart attack, and are more likely to have a rarer type of heart attack.
Fourteen-year-old Athena Tran celebrated an important personal milestone this week: It's been one year since she received a heart transplant.
The leading cause of death in the U.S. is shifting from heart disease to cancer at varying paces across the country, according to Stanford research.
In this final piece in the Understanding AFib series, physician Randall Stafford offers evidence-based advice for remaining healthy with the condition.
In this sixth piece in the Understanding AFib series, physician Randall Stafford explains how medications, procedures and pacemakers can be used for AFib.
A team of Stanford researchers has designed a new flexible "micropillar" electrode to study the behavior of heart cells without affecting their behavior.
In the fifth installment in the Understanding AFib series, Randall Stafford explains how to measure your heart rate and pay attention to your heart rhythm.
A team of Stanford Biodesign innovators has developed a video to increase awareness in India of a serious heart condition, RHD.
In this fourth post in the Understanding AFib series, physician Randall Stafford explains different drugs that are used to slow down the heart.
In the latest installment in the series Understanding AFib, Randall Stafford explains the different types of blood thinners.
In the second piece in a the Understanding AFib series, physician Randall Stafford examines which patients should use blood thinners.
In the first of a series on atrial fibrillation, physician Randall Stafford explains the condition and how it increases the risk of stroke.
Scientists have developed an algorithm that combines genome sequence data and electronic health information to predict risk for genetic disease.
John Farquhar, a beloved mentor, and pioneer in cardiovascular disease prevention at Stanford, died Aug. 22 at the age of 91.